AI assistant
Riot Platforms, Inc. — Director's Dealing 2017
Jul 3, 2017
30793_dirs_2017-07-03_bc80a9b2-e5a3-46c5-8018-72969c14be1a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bioptix, Inc. (BIOP)
CIK: 0001167419
Period of Report: 2017-06-30
Reporting Person: MCGONEGAL JEFFREY (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | Common Stock | A | 20000 | $0.00 | Acquired | 20000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | Stock Option (Right to Buy) | $ | J | 67172 | Disposed | Common Stock (67172) | Direct |
Footnotes
F1: Represents a restricted stock award under the Bioptix, Inc. Amended & Restated Equity Incentive Plan (the "Restricted Stock Award"), granted as compensation in connection with the Reporting Person's service pursuant to that certain retention agreement dated June 30, 2017 in connection with the Reporting Person's retention as Chief Financial Officer of the Company. The restricted stock award shall vest on the Employment Termination Date, as defined therein.
F2: Mr. McGonegal agreed to waive his rights to 67,172 outstanding stock options in exchange for a one-time lump-sum payment of $50,000